David Rolfe
Wedgewood Partners
David Rolfe Procter & Gamble Company stake
total: 97
Wedgewood Partners PG trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2016 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2016 Q3
According to 2026 Q2 report, David Rolfe doesn't hold any Procter & Gamble Company (PG) shares. To date, the estimated cost basis is nearly $84.58 for "buy" trades and estimated average "sell" price is $84.58. Wedgewood Partners first purchased PG in 2016 Q2, initially acquiring 2,400 shares. Since the initial investment in Procter & Gamble Company (PG), Wedgewood Partners has made 1 more transaction.
When did David Rolfe sell Procter & Gamble Company (PG)?
David Rolfe sold off the entire Procter & Gamble Company (PG) position in 2016 Q3.
When did David Rolfe buy Procter & Gamble Company (PG)?
David Rolfe first invested in Procter & Gamble Company (PG) in 2016 Q2 at the reported quarter-end price of $84.58 per share.
What's the cost basis of Wedgewood Partners's PG stake?
The estimated cost basis for Procter & Gamble Company (PG) stake is around $84.58 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $84.58
- Weighted AVG sell price:
- $84.58
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.